Long-term effect of intravitreal injection of anti-VEGF agent for visual acuity and chorioretinal atrophy progression in myopic choroidal neovascularization
Graefe's Archive for Clinical and Experimental Ophthalmology, 05/01/2012Oishi A et al.
Anti–VEGF therapy for myopic choroidal neovascularization (mCNV) is effective for vision improvement in the long term. On the other hand, development or enlargement of chorioretinal atrophy frequently occurred, and affected visual improvement. Strategies to manage atrophy should be the next step in achieving better visual outcome upon mCNV treatment.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.